Xtant Medical Holdings, Inc.
XTNT
$0.35
-$0.03-7.95%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -365.15% | -5,425.86% | 101.80% | 126.04% | 191.95% |
| Total Depreciation and Amortization | -56.54% | -50.28% | 58.45% | 8.20% | 17.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 567.38% | 18.02% | -26.22% | 6.80% | -31.70% |
| Change in Net Operating Assets | -17.97% | -0.33% | 76.01% | -39.05% | -19.82% |
| Cash from Operations | -672.73% | -265.41% | 709.02% | 368.45% | 125.08% |
| Capital Expenditure | 32.51% | 83.71% | 41.22% | 79.56% | 35.11% |
| Sale of Property, Plant, and Equipment | 14.29% | -4.17% | -75.24% | 14.74% | -41.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,537.54% | 994.14% | 925.40% | 332.90% | 33.96% |
| Total Debt Issued | -1.46% | -93.52% | -14.56% | -3.70% | -21.88% |
| Total Debt Repaid | 39.59% | 42.79% | 4.23% | -22.10% | 5.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 11.54% | -11.11% | 85.29% | 40.86% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2,066.67% | 100.00% | 91.62% |
| Cash from Financing | 1,494.86% | -1,344.50% | -314.75% | -208.60% | -89.71% |
| Foreign Exchange rate Adjustments | 105.26% | 0.00% | 255.05% | 300.00% | -58.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.10% | -557.89% | 873.06% | 124.13% | 87.59% |